Cargando…

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis

BACKGROUND: Central nervous system (CNS) metastasis is common in advanced melanoma patients. New treatment options have improved overall prognosis, but information is lacking for patients with CNS metastases. We investigated treatment patterns and survival outcomes in older melanoma patients with an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadetsky, Natalia, Hernandez, Alexandra, Wallick, Chris J., McKenna, Edward F., Surinach, Andy, Colburn, Dawn E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476818/ https://www.ncbi.nlm.nih.gov/pubmed/32667719 http://dx.doi.org/10.1002/cam4.3256

Ejemplares similares

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study
por: Tawbi, Hussein, et al.
Publicado: (2021)

Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset
por: Ambs, Anita, et al.
Publicado: (2008)

Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis
por: Ades, Steven, et al.
Publicado: (2022)

Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma
por: Tawbi, Hussein, et al.
Publicado: (2022)

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
por: Beebe‐Dimmer, Jennifer L., et al.
Publicado: (2019)

Associations between initiating antihypertensive regimens on stage I–III colorectal cancer outcomes: A Medicare SEER cohort analysis
por: Balkrishnan, Rajesh, et al.
Publicado: (2021)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis
por: Ailawadhi, Sikander, et al.
Publicado: (2017)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice
por: Mileshkin, Linda, et al.
Publicado: (2022)

Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource
por: Lam, Clara, et al.
Publicado: (2018)

Associations between cancer and Alzheimer's disease in a U.S. Medicare population
por: Freedman, Daryl Michal, et al.
Publicado: (2016)

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005
por: Yasmeen, Shagufta, et al.
Publicado: (2013)

Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER‐Medicare study
por: Shao, Changxia, et al.
Publicado: (2019)

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data
por: Goto, Daisuke, et al.
Publicado: (2019)

Front‐line treatment patterns in multiple myeloma: An analysis of U.S.‐based electronic health records from 2011 to 2019
por: Kumar, Shaji, et al.
Publicado: (2021)

Pattern of distant metastases in primary extrahepatic bile‐duct cancer: A SEER‐based study
por: Wang, Xuan, et al.
Publicado: (2018)

Comparison of SEER Treatment Data With Medicare Claims
por: Noone, Anne-Michelle, et al.
Publicado: (2016)

Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis
por: Mattke, Soeren, et al.
Publicado: (2023)

Multiple metastases in central nervous system and subdural hematoma in the course of melanoma
por: Woźniak-Dąbrowska, Kamila, et al.
Publicado: (2022)

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
por: Karz, Alcida, et al.
Publicado: (2022)

Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population‐based study
por: Xiao, Yu, et al.
Publicado: (2020)

Impact of serious mental illness on the treatment and mortality of older patients with locoregional high‐grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER‐Medicare patients diagnosed between 2006 and 2013
por: Fried, Dennis A., et al.
Publicado: (2019)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States
por: Paluri, Ravi, et al.
Publicado: (2022)

Resection of the primary tumor improves survival in patients with gastro‐entero‐pancreatic neuroendocrine neoplasms with liver metastases: A SEER‐based analysis
por: Zheng, Mengzhen, et al.
Publicado: (2019)

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
por: Beebe-Dimmer, Jennifer L., et al.
Publicado: (2018)

Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases
por: Seifert, Heike, et al.
Publicado: (2015)

Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study
por: Zhou, Huaqiang, et al.
Publicado: (2017)

Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis
por: Brar, Gagandeep, et al.
Publicado: (2020)

Opportunities for Personalizing Colorectal Cancer Care: An Analysis of SEER-Medicare Data
por: Rivers, Zachary T., et al.
Publicado: (2022)

Incidence and survival of childhood central nervous system tumors in Denmark, 1997–2019
por: Helligsoe, Anne Sophie Lind, et al.
Publicado: (2021)

Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
por: Beebe-Dimmer, Jennifer L., et al.
Publicado: (2018)

Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis
por: Stafford, M.Y. Cynthia, et al.
Publicado: (2022)

Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases
por: Alfaar, Ahmad S., et al.
Publicado: (2017)

Competing‐risks model for predicting the prognosis of penile cancer based on the SEER database
por: Yang, Jin, et al.
Publicado: (2019)

SEER-MHOS: A New Federal Collaboration on Cancer Outcomes Research
por: Clauser, Steven B., et al.
Publicado: (2008)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
por: Liu, Hong, et al.
Publicado: (2019)

Uterine leiomyosarcoma with central nervous system metastases
por: Abrahão, Carina Meira, et al.
Publicado: (2015)

Cytokine Landscape in Central Nervous System Metastases
por: Marin, Julie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rdqv0lr3qi31khgo4a7r9e6f0d